STERIS plc Ordinary Shares (STE) was Initiated by Goldman to “Neutral” and the brokerage firm has set the Price Target at $71. Goldman advised their investors in a research report released on Nov 30, 2016.
On the company’s financial health, STERIS plc Ordinary Shares reported $0.89 EPS for the quarter, missing the analyst consensus estimate by $ -0.01 based on the information available during the earnings call on Nov 2, 2016. Analyst had a consensus of $0.90. The company had revenue of $646.40 million for the quarter, compared to analysts expectations of $667.29 million. The company’s revenue was up 31.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.83 EPS.
STERIS plc Ordinary Shares opened for trading at $66.65 and hit $67.07 on the upside on Tuesday, eventually ending the session at $66.89, with a gain of 0.03% or 0.02 points. The heightened volatility saw the trading volume jump to 3,58,616 shares. Company has a market cap of $5,699 M.
In a different news, on Nov 16, 2016, John Adam Zangerle (VP, Gen Counsel, and Sec.) sold 2,200 shares at $67.00 per share price. According to the SEC, on Nov 7, 2016, Cynthia L Feldmann (director) sold 4,744 shares at $65.04 per share price. On Sep 7, 2016, Richard Martin Steeves (director) sold 204,778 shares at $71.12 per share price, according to the Form-4 filing with the securities and exchange commission.